Director, Validation

Director Validation: Remote OR Hybrid Philadelphia PA

Cabaletta Bio (Nasdaq: CABA) is a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically for patients with autoimmune diseases. The CABA platform encompasses two complementary strategies which aim to advance the discovery and development of engineered T cell therapies with the potential to become deep and durable perhaps curative treatments for a broad range of autoimmune diseases. The lead CARTA (Chimeric Antigen Receptor T cells for Autoimmunity) strategy is prioritizing the development of rese-cel a 4-1BB-containing fully human CD19-CAR T cell investigational therapy. Rese-cel is currently being evaluated in the RESET (REstoring SElf-Tolerance) clinical development program spanning multiple therapeutic areas including rheumatology neurology and dermatology. Cabaletta Bios headquarters and labs are located in Philadelphia PA. For more information please visit and connect with us on LinkedIn.

Uniquely Differentiated. Rapid. Elegant.

At Cabaletta we are driven by the shared mission of developing cures where a patients own cells are used to fight disease. We are building a culture grounded in the knowledge that successful cures can be achieved for patients if every member of the Cabaletta is focused on the success of the team. To nurture this we make an active commitment to the well-being and continuous growth of each employee who joins the this way we are not only working to improve the lives of patients but of everyone involved. #CabalettaCrew.

Were proud to be a Great Place to Work-Certified company! #GPTWcertified Check out what our employees say makes working here so great:Working at Cabaletta Bio Inc Great Place to Work

Director Validation: Remote OR Hybrid Philadelphia PA

Position Summary

The Director Validation is responsible for developing implementing and maintaining the laboratory validation program supporting Research Translational Medicine Manufacturing Sciences and Technology Analytical Development Process Development and other laboratory functions. This role provides strategic and operational leadership for qualification and validation of laboratory instruments equipment computerized systems and supporting infrastructure to ensure compliance with FDA EMA ICH and GxP requirements in preparation for Biologics License Application (BLA) submission and commercial launch.

The Director will establish a sustainable risk-based validation lifecycle aligned with regulatory expectations for advanced therapies and autologous cell therapy products. Working cross-functionally with Quality Assurance Quality Control Information Technology Research & Development Regulatory Affairs and external vendors this position will ensure validated laboratory systems generate reliable attributable and inspection-ready data throughout product development and commercialization.

Primary Responsibilities

Validation Program Leadership

• Develop and execute the strategic roadmap for laboratory validation supporting transition from clinical-stage development through BLA submission and commercial launch.
• Establish governance for laboratory validation activities across R&D organizations.
• Develop policies procedures standards templates and lifecycle management processes for validation activities.
• Build a scalable validation framework consistent with current regulatory expectations for computerized systems and laboratory equipment.
• Lead continuous improvement initiatives to enhance validation efficiency while maintaining regulatory compliance.

Equipment and Instrument Qualification

• Direct qualification activities for laboratory equipment and instrumentation including:
• Installation Qualification (IQ)
• Operational Qualification (OQ)
• Performance Qualification (PQ)
• Requalification
• Decommissioning
• Ensure qualification documentation is scientifically justified and risk-based.
• Define validation strategies based on intended use product impact patient safety and data integrity risk.

Computerized Systems Validation (CSV)

• Lead validation of laboratory computerized systems including:
• Laboratory Information Management Systems (LIMS)
• Electronic Lab Notebooks (ELN)
• Instrument software
• Scientific applications
• Laboratory data acquisition systems
• Ensure systems comply with:
• 21 CFR Part 11
• Annex 11
• ALCOA data integrity principles
• GAMP 5 guidance
• Partner with Information Technology and system owners to manage system lifecycle upgrades patches and periodic review.

Inspection Readiness

• Develop inspection-ready validation documentation supporting FDA pre-license inspections and regulatory audits.
• Ensure validation packages are complete traceable scientifically defensible and readily retrievable.
• Lead inspection readiness activities related to laboratory validation.
• Support regulatory inspections by serving as subject matter expert for:
• Equipment qualification
• Computerized systems validation
• Data integrity
• Validation lifecycle management
• Lead remediation activities arising from inspections or internal audits.

Quality Systems

• Ensure validation activities integrate effectively within the Quality Management System.
• Review and approve:
• Validation Plans
• User Requirements Specifications
• Risk Assessments
• Functional Specifications
• IQ/OQ/PQ Protocols
• Summary Reports
• Traceability Matrices
• Periodic Reviews
• Support change control assessments for validated systems.
• Ensure deviations are appropriately investigated and resolved.
• Monitor validation metrics and report program status to senior leadership.

Cross-Functional Leadership

• Partner closely with:
• Quality Assurance / Quality Control
• Analytical Development
• Process Development
• Translational Medicine
• Manufacturing Sciences and Technology
• Information Technology
• External Contract Laboratories
• Provide validation expertise during laboratory expansion technology transfers implementation of new analytical platforms and adoption of automation technologies.
• Evaluate validation impact of new laboratory technologies and digital transformation initiatives.

Vendor Management

• Oversee validation deliverables from equipment manufacturers software suppliers and validation consultants.
• Review vendor qualification documentation.
• Ensure vendor documentation meets company quality standards and regulatory expectations.
• Manage external validation resources as needed.

People Leadership

• Build mentor and develop a high-performing validation organization.
• Establish goals performance expectations and professional development plans.
• Foster a culture emphasizing quality scientific rigor collaboration and continuous improvement.

Required Qualifications

Education

• Bachelors degree in Engineering Life Sciences Computer Science Pharmaceutical Sciences or related discipline required.

Experience

• 12 years of experience within biotechnology pharmaceutical cell therapy gene therapy or biologics industries.
• Minimum 5 years leading validation organizations.
• Demonstrated experience supporting BLA NDA or commercial biologics submissions.
• Experience establishing validation programs in rapidly growing biotechnology organizations.
• Experience supporting FDA inspections with positive outcomes.
• Strong knowledge of laboratory operations supporting advanced therapies.

Technical Expertise

Extensive knowledge of:

• Equipment Qualification (IQ/OQ/PQ)
• Computerized Systems Validation
• Risk-based Validation
• GAMP 5
• 21 CFR Partsseries
• 21 CFR Part 58 (where applicable)
• ICH Q9
• ICH Q10
• FDA Data Integrity Guidance
• EU GMP Annex 11
• ALCOA principles
• Validation lifecycle management
• Laboratory automation
• Analytical instrumentation

Experience with:

• Flow cytometry platforms
• Cell counting instruments
• PCR and qPCR systems
• Bioanalytical instrumentation
• Laboratory information systems
• Scientific software applications

Knowledge of autologous cell therapy manufacturing and analytical workflows strongly preferred.

Our name Cabaletta is derived from the operatic term that represents a rapid repetitive and technically challenging section of an operatic aria designed to showcase the skills of the lead singer. Analogously Cabaletta Bio strives to achieve rapid and repetitive product development building on our indication prioritization and biologic platform that targets the driver of specific autoimmune diseases without the need for long-term immunosuppression.

For more information please visit most important asset is our people and we offer competitive benefits PTO and stock option plans.

Cabaletta Bio is an equal opportunity employer. We do not discriminate on the basis of race color gender gender identity sexual orientation age religion national or ethnic origin disability protected veteran status or any other basis protected by applicable law.

Cabaletta Bio Inc. does not accept unsolicited resumes from recruiters employment agencies or staffing firms. To conduct business with Cabaletta a Master Services Agreement (MSA) must be executed and confirmed prior to submitting any information relating to a potential candidate. Without a signed MSA Cabaletta shall not be responsible to any individual or entity for any payment relating to any form of fee or compensation.

And if a resume or candidate is submitted by a recruiter an employment agency or a staffing firm without a fully executed MSA Cabaletta has the unrestricted right to pursue and hire any of those candidate(s) without any legal or financial responsibility to the recruiter agency and/or firm.

#LI-REMOTE